{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:04:37Z","timestamp":1792029877145,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.revmed.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:44:21Z","timestamp":1689263061000},"page":"423-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["French national diagnostic and care protocol for Sj\u00f6gren's disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Val\u00e9rie","family":"Devauchelle-Pensec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas-Alexis","family":"Benyoussef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Boisrame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Cochener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtane","family":"Nocturne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques Eric","family":"Gottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Labalette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"M\u2019Bwang Seppoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Orliaguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00e8le","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2023.07.001_bib0505","unstructured":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren's Syndrome: a consensus and data-driven methodology involving three international patient cohorts\u00a0\u2013\u00a0PubMed [WWW Document], n.d. URL https:\/\/pubmed.ncbi.nlm.nih.gov\/27785888\/ [accessed 1.12.22]."},{"issue":"Suppl. 112","key":"10.1016\/j.revmed.2023.07.001_bib0510","first-page":"210","article-title":"Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sj\u00f6gren's syndrome","volume":"36","author":"Alunno","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0515","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/rheumatology\/key392","article-title":"Is early-onset primary Sj\u00f6gren's syndrome a worse prognosis form of the disease?","volume":"58","author":"Anquetil","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2023.07.001_bib0520","first-page":"3507484","article-title":"Lipsch\u00fctz genital ulceration as initial manifestation of primary Sj\u00f6gren's syndrome","volume":"2018","author":"de Castro Coelho","year":"2018","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0525","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/ard.2007.074203","article-title":"Exocrine function in primary Sj\u00f6gren's syndrome: natural course and prognostic factors","volume":"67","author":"Haldorsen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0530","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chest.2020.10.011","article-title":"Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren's","volume":"159","author":"Lee","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2023.07.001_bib0535","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.22115","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome in a French multiracial\/multiethnic area","volume":"66","author":"Maldini","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.revmed.2023.07.001_bib0540","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40674-017-0076-9","article-title":"Neurological complications of Sj\u00f6gren's syndrome: diagnosis and management","volume":"3","author":"McCoy","year":"2017","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0545","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1093\/rheumatology\/kez052","article-title":"Lymphomas complicating primary Sj\u00f6gren's syndrome: from autoimmunity to lymphoma","volume":"60","author":"Nocturne","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2023.07.001_bib0550","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren's syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0555","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaut.2010.06.014","article-title":"Memory B-cell aggregates in skin biopsy are diagnostic\u2026 for primary Sj\u00f6gren's syndrome","volume":"35","author":"Roguedas","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2023.07.001_bib0560","unstructured":"TFOS DEWS II Epidemiology Report\u00a0\u2013\u00a0PubMed [WWW Document], n.d. URL https:\/\/pubmed.ncbi.nlm.nih.gov\/28736337\/ [accessed 1.12.22]."},{"key":"10.1016\/j.revmed.2023.07.001_bib0565","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","article-title":"Diagnostic tests in the Sicca syndrome","volume":"82","author":"van Bijsterveld","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0570","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0575","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/978-1-4615-0717-8_157","article-title":"Alternative reference values for tear film break up time in normal and dry eye populations","volume":"506","author":"Abelson","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0580","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-304619","article-title":"Diagnosing the severity of dry eye: a clear and practical algorithm","volume":"98","author":"Baudouin","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0585","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jemt.22586","article-title":"Entropy of corneal nerve fibers distribution observed by laser scanning confocal microscopy: a non-invasive quantitative method to characterize the corneal innervation in Sj\u00f6gren's syndrome patients","volume":"78","author":"Bianciardi","year":"2015","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.revmed.2023.07.001_bib0590","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","article-title":"Primary Sj\u00f6gren's syndrome and the eye","volume":"65","author":"Bjordal","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0595","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/01676830.2011.648802","article-title":"A review of the complications of lacrimal occlusion with punctal and canalicular plugs","volume":"31","author":"Bourkiza","year":"2012","journal-title":"Orbit"},{"key":"10.1016\/j.revmed.2023.07.001_bib0600","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.revmed.2023.07.001_bib0605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","article-title":"Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses","volume":"33","author":"Chalmers","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.revmed.2023.07.001_bib0610","first-page":"563","article-title":"Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye","volume":"15","author":"Chen","year":"2009","journal-title":"Mol Vis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0615","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0161-6420(92)31947-5","article-title":"Comparison of fluorescein and rose bengal staining","volume":"99","author":"Feenstra","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2023.07.001_bib0620","doi-asserted-by":"crossref","first-page":"285851","DOI":"10.1155\/2012\/285851","article-title":"The role of medications in causing dry eye","volume":"2012","author":"Fraunfelder","year":"2012","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0625","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ajo.2012.11.009","article-title":"Tear meniscus evaluation by anterior segment swept-source optical coherence tomography","volume":"155","author":"Fukuda","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0630","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/bjophthalmol-2012-301767","article-title":"Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye","volume":"96","author":"Liew","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0635","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.exer.2013.08.011","article-title":"The role of corneal afferent neurons in regulating tears under normal and dry eye conditions","volume":"117","author":"Meng","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.revmed.2023.07.001_bib0640","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00003226-200404000-00010","article-title":"The repeatability of clinical measurements of dry eye","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.revmed.2023.07.001_bib0645","unstructured":"Pisella P-J, et al. 2015 - Ocular surface report 2015 [submitted to] Soc.pdf, n.d."},{"key":"10.1016\/j.revmed.2023.07.001_bib0650","series-title":"Ocular surface: 2015 report [presented to the] French Society of Ophthalmology","author":"Pisella","year":"2015"},{"key":"10.1016\/j.revmed.2023.07.001_bib0655","unstructured":"Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease\u00a0\u2013\u00a0PubMed [WWW Document], n.d. URL https:\/\/pubmed.ncbi.nlm.nih.gov\/11527941\/ [accessed 1.12.22]."},{"key":"10.1016\/j.revmed.2023.07.001_bib0660","first-page":"CD009729","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2023.07.001_bib0665","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.revmed.2023.07.001_bib0670","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0675","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2014.01.028","article-title":"Scleral lenses in the management of ocular surface disease","volume":"121","author":"Schornack","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2023.07.001_bib0680","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1477-7525-2-44","article-title":"Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sj\u00f6gren's syndrome-related dry eye","volume":"2","author":"Vitale","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.revmed.2023.07.001_bib0685","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","article-title":"A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren's Syndrome International Registry","volume":"149","author":"Whitcher","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0690","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1167\/iovs.13-11798","article-title":"A study of the short-term effect of artificial tears on contrast sensitivity in patients with Sj\u00f6gren's syndrome","volume":"54","author":"Zhang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.revmed.2023.07.001_bib0695","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clindermatol.2006.07.005","article-title":"Sj\u00f6gren's syndrome in dermatology","volume":"24","author":"Fox","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0700","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jdcr.2017.04.011","article-title":"Cutaneous purpura of Sj\u00f6gren syndrome successfully treated with hydroxychloroquine","volume":"3","author":"Hile","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.revmed.2023.07.001_bib0705","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1468-3083.2006.01441.x","article-title":"Primary Gougerot-Sj\u00f6gren syndrome: a dermatological approach","volume":"20","author":"Roguedas","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0710","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clindermatol.2018.04.009","article-title":"Less common rheumatologic disorders: current concepts of skin and systemic manifestations","volume":"36","author":"Paravar","year":"2018","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.revmed.2023.07.001_bib1000","first-page":"1","article-title":"[Conduite \u00e0 tenir devant une s\u00e9cheresse buccale]","volume":"11","author":"Boisram\u00e9","year":"2016","journal-title":"Med Buccale"},{"key":"10.1016\/j.revmed.2023.07.001_bib0715","doi-asserted-by":"crossref","first-page":"e0189507","DOI":"10.1371\/journal.pone.0189507","article-title":"Dental implants in Sj\u00f6gren's syndrome patients: a systematic review","volume":"12","author":"Almeida","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2023.07.001_bib0720","first-page":"CD009603","article-title":"Interventions for the management of dry mouth: non-pharmacological interventions","author":"Furness","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2023.07.001_bib0725","first-page":"e217","article-title":"Implants in patients with oral manifestations of autoimmune or mucocutaneous diseases\u00a0\u2013\u00a0A systematic review","volume":"24","author":"Strietzel","year":"2019","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.revmed.2023.07.001_bib0730","unstructured":"Antiinflammatory action of glucocorticoids \u2013\u00a0new mechanisms for old drugs\u00a0\u2013 PubMed [WWW Document], n.d. URL https:\/\/pubmed.ncbi.nlm.nih.gov\/16236742\/ [accessed 1.12.22]."},{"key":"10.1016\/j.revmed.2023.07.001_bib0735","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/annrheumdis-2020-218599","article-title":"Efficacy and safety of abatacept in active primary Sj\u00f6gren's syndrome: results of a phase III, randomised, placebo-controlled trial","volume":"80","author":"Baer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0740","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2213-2600(20)30356-8","article-title":"Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.revmed.2023.07.001_bib0745","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.40093","article-title":"Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sj\u00f6gren's syndrome","volume":"69","author":"Bowman","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0750","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(21)02251-0","article-title":"Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sj\u00f6gren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial","volume":"399","author":"Bowman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.07.001_bib0755","doi-asserted-by":"crossref","first-page":"e001064","DOI":"10.1136\/rmdopen-2019-001064","article-title":"Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sj\u00f6gren's syndrome","volume":"5","author":"Brito-Zer\u00f3n","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.revmed.2023.07.001_bib0760","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/annrheumdis-2020-217481","article-title":"Efficacy of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sj\u00f6gren syndrome refractory to rituximab alone","volume":"79","author":"Chevalier","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0765","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40265-018-1039-7","article-title":"Pharmacotherapy for neuromyelitis optica spectrum disorders: current management and future options","volume":"79","author":"Collongues","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.revmed.2023.07.001_bib0770","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/rheumatology\/kez430","article-title":"Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy","volume":"59","author":"Combier","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2023.07.001_bib0775","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2007.083865","article-title":"Reduction of fatigue in Sj\u00f6gren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study","volume":"67","author":"Dass","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0780","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinaemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2023.07.001_bib0785","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bjh.15120","article-title":"Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sj\u00f6gren's syndrome (pSS)","volume":"184","author":"Demaria","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0790","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3899\/jrheum.190076","article-title":"Rituximab-associated vasculitis flare: incidence, predictors, and outcome","volume":"47","author":"Desbois","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0795","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sj\u00f6gren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2023.07.001_bib0800","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/annrheumdis-2018-214720","article-title":"Treatment of primary Sj\u00f6gren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity","volume":"78","author":"D\u00f6rner","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0805","first-page":"e142","article-title":"Interleukin 6 receptor inhibition in primary Sj\u00f6gren syndrome: a multicentre double-blind randomised placebo-controlled trial","volume":"2","author":"Felten","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0810","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S2665-9913(19)30135-3","article-title":"Assessment of the anti-CD40 antibody iscalimab in patients with primary Sj\u00f6gren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"2","author":"Fisher","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0815","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0820","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.2014.7682","article-title":"Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial","volume":"312","author":"Gottenberg","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2023.07.001_bib0825","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(11)61649-8","article-title":"Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial","volume":"378","author":"Kappos","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.07.001_bib0830","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clineuro.2004.10.001","article-title":"Pulse-cyclophosphamide in the treatment of ataxic sensory and cranial nerve neuropathy associated with Sjogren's syndrome","volume":"107","author":"Kastrup","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.revmed.2023.07.001_bib0835","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","article-title":"Topical treatment with nerve growth factor for corneal neurotrophic ulcers","volume":"338","author":"Lambiase","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2023.07.001_bib0840","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5301\/ejo.5000779","article-title":"Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial","volume":"26","author":"Leonardi","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0845","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0850","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sj\u00f6gren's syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2023.07.001_bib0855","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1474-4422(12)70093-5","article-title":"Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial","volume":"11","author":"Nobile-Orazio","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0860","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren's syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0865","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2010.1014","article-title":"Treatment of primary Sj\u00f6gren's syndrome: a systematic review","volume":"304","author":"Ramos-Casals","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2023.07.001_bib0870","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/ICO.0b013e318074e460","article-title":"Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye","volume":"26","author":"Roberts","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.revmed.2023.07.001_bib0875","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.1992.tb14851.x","article-title":"Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine","volume":"127","author":"Ruzicka","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0880","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sj\u00f6gren's syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0885","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1002\/art.25000","article-title":"Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis","volume":"60","author":"S\u00e8ne","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2023.07.001_bib0890","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S2665-9913(19)30160-2","article-title":"Abatacept treatment for patients with early active primary Sj\u00f6gren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)","volume":"2","author":"van Nimwegen","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0895","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.rbr.2016.05.009","article-title":"Are the women with Sj\u00f6gren's Syndrome satisfied with their sexual activity?","volume":"57","author":"Isik","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"10.1016\/j.revmed.2023.07.001_bib0900","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0301-2115(95)02224-U","article-title":"Gynaecological aspects of primary Sjogren's syndrome","volume":"63","author":"Marchesoni","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0905","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3899\/jrheum.141475","article-title":"Quality of sexual life in women with primary Sj\u00f6gren syndrome","volume":"42","author":"Priori","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0910","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/ard.53.9.569","article-title":"Obstetric and gynaecological profile in patients with primary Sj\u00f6gren's syndrome","volume":"53","author":"Skopouli","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.07.001_bib0915","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0368-2315(06)76391-8","article-title":"[Sj\u00f6gren syndrome in obstetric and gynecology: literature review]","volume":"35","author":"Picone","year":"2006","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.revmed.2023.07.001_bib0920","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.autrev.2018.06.015","article-title":"Arthritis in primary Sj\u00f6gren's syndrome: characteristics, outcome and treatment from French multicenter retrospective study","volume":"18","author":"Mirouse","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2023.07.001_bib0925","first-page":"362","article-title":"A multicentre study of 95 biopsy-proven cases of renal disease in primary Sj\u00f6gren's syndrome","volume":"56","author":"Jasiek","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2023.07.001_bib0930","doi-asserted-by":"crossref","first-page":"E407","DOI":"10.3390\/jcm9020407","article-title":"Therapeutic options for the treatment of interstitial lung disease related to connective tissue diseases. A narrative review","volume":"9","author":"Vacchi","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.revmed.2023.07.001_bib0935","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":"Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders","volume":"17","author":"Jarius","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.revmed.2023.07.001_bib0940","unstructured":"Neuromyelitis optica and non-organ-specific autoimmunity\u00a0\u2013\u00a0PubMed [WWW Document], n.d. URL https:\/\/pubmed.ncbi.nlm.nih.gov\/18195142\/ [accessed 1.12.22]."},{"key":"10.1016\/j.revmed.2023.07.001_bib0945","doi-asserted-by":"crossref","first-page":"e3632","DOI":"10.1097\/MD.0000000000003632","article-title":"Sj\u00f6gren sensory neuronopathy (Sj\u00f6gren Ganglionopathy): long-term outcome and treatment response in a series of 13 cases","volume":"95","author":"Pereira","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2023.07.001_bib0950","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/acr.20495","article-title":"Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sj\u00f6gren's syndrome: a national multicentric retrospective study","volume":"63","author":"Rist","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.revmed.2023.07.001_bib0955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol"},{"issue":"18","key":"10.1016\/j.revmed.2023.07.001_bib0990","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.revmed.2023.07.001_bib0995","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.revmed.2023.07.001_bib0960","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1136\/annrheumdis-2018-213718","article-title":"Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus","volume":"77","author":"Barsalou","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 126","key":"10.1016\/j.revmed.2023.07.001_bib0965","first-page":"95","article-title":"Autoimmune congenital heart block and primary Sj\u00f6gren's syndrome: characterisation and outcomes of 49 cases","volume":"38","author":"Brito-Zer\u00f3n","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0970","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/S2665-9913(19)30069-4","article-title":"Routine repeated echocardiographic monitoring of fetuses exposed to maternal anti-SSA antibodies: time to question the dogma","volume":"1","author":"Costedoat-Chalumeau","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0975","first-page":"1734","article-title":"Pregnancy outcome in patients with primary Sj\u00f6gren's syndrome. A case-control study","volume":"32","author":"Haga","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0980","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2023.07.001_bib0985","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fatal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323006793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323006793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:45Z","timestamp":1759337205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866323006793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0248866323006793"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2023.07.001","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French national diagnostic and care protocol for Sj\u00f6gren's disease","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}